Sather Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279K Sell
9,945
-653
-6% -$17.4K 0.02% 86
2025
Q4
$264K Sell
10,598
-160
-1% -$4.04K 0.01% 93
2025
Q3
$274K Buy
10,758
+963
+10% +$23.8K 0.01% 88
2025
Q2
$237K Hold
9,795
0.01% 101
2025
Q1
$248K Hold
9,795
0.02% 85
2024
Q4
$260K Hold
9,795
0.02% 79
2024
Q3
$283K Hold
9,795
0.02% 79
2024
Q2
$274K Sell
9,795
-4,100
-30% -$113K 0.02% 73
2024
Q1
$386K Hold
13,895
0.03% 66
2023
Q4
$400K Hold
13,895
0.03% 60
2023
Q3
$461K Hold
13,895
0.04% 60
2023
Q2
$510K Hold
13,895
0.04% 63
2023
Q1
$567K Hold
13,895
0.05% 61
2022
Q4
$712K Hold
13,895
0.06% 67
2022
Q3
$608K Hold
13,895
0.07% 47
2022
Q2
$729K Hold
13,895
0.08% 43
2022
Q1
$719K Buy
+13,895
New +$721K 0.06% 50

Other funds holding PFE

Sather Financial Group's PFE Position: Q1 2026 in Review

Sather Financial Group reduced its Pfizer (PFE) stake by 6.2% in Q1 2026, selling an estimated $17.4K and leaving 9,945 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #86.

Sather Financial Group first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $729K in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sather Financial Group held 9,945 shares of Pfizer worth $279K as of Q1 2026.
  • Sather Financial Group sold 653 Pfizer shares in Q1 2026, an estimated $17.4K.
  • Pfizer made up 0.02% of Sather Financial Group's portfolio in Q1 2026, its #86 holding.
  • Sather Financial Group first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
  • Sather Financial Group's Pfizer position peaked at $729K in Q2 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sather Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.